DILUTING MEDIUM FOR INSULIN ZINC INJECTABLE SUSPENSION 1 ML / 1 ML
WATER : 1 ML / 1 ML · DIN 02024489 · NOVO NORDISK CANADA INC
Health Canada status: CANCELLED POST MARKET
What is DILUTING MEDIUM FOR INSULIN ZINC INJECTABLE SUSPENSION?
DILUTING MEDIUM FOR INSULIN ZINC INJECTABLE SUSPENSION 1 ML / 1 ML contains WATER : 1 ML / 1 ML. It is listed in the Health Canada Drug Product Database under DIN 02024489, held by NOVO NORDISK CANADA INC, supplied as LIQUID for SUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as cancelled post market, status dated 12-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02024489 |
|---|---|
| Brand name | DILUTING MEDIUM FOR INSULIN ZINC INJECTABLE SUSPENSION |
| Generic / active ingredient | WATER : 1 ML / 1 ML |
| Manufacturer | NOVO NORDISK CANADA INC |
| Strength | 1 ML / 1 ML |
| Dosage form | LIQUID |
| Route of administration | SUBCUTANEOUS ; INTRAVENOUS ; INTRAMUSCULAR |
| Schedule | Ethical |
| ATC code | V07AB SOLVENTS AND DILUTING AGENTS, INCL IRRIGAT SOLUT |
| AHFS class | 88:20.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-Aug-1999 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code V07AB SOLVENTS AND DILUTING AGENTS, INCL IRRIGAT SOLUT. 23 of 62 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 0.9% SODIUM CHLORIDE INJECTION USP | 9 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02304341 |
| BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP | 9 MG | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00037818 |
| BACTERIOSTATIC WATER FOR INJECTION USP | 30 ML / 30 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00038202 |
| BACTERIOSTATIC WATER FOR INJECTION USP-PRE-FILLED SYRINGE | 99.1 % | LIQUID | PFIZER CANADA ULC | MARKETED | DIN 02215721 |
| BSS PLUS | 0.042 % | SOLUTION ; KIT | ALCON CANADA INC | MARKETED | DIN 00568082 |
| BSS STERILE IRRIGATING SOLUTION | 0.17 % | SOLUTION | ALCON CANADA INC | MARKETED | DIN 00512990 |
| GLYCERINATED PHENOL SALINE | 0.4 % | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00298417 |
| PH 12 STERILE DILUENT FOR FLOLAN | 94 MG | LIQUID | GLAXOSMITHKLINE INC | MARKETED | DIN 02443651 |
| PHENOL SALINE INJ | 0.9 % | LIQUID | ALK-ABELLO INC | MARKETED | DIN 00298409 |
| SODIUM CHLORIDE BACTERIOSTATIC INJ | 9 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 00402249 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.